Metraipolis › archive › dc_1ec51180d24b
Prognostic Impact of Unplanned Hospitalization During First-Line Gemcitabine Plus Nab-Paclitaxel Therapy for Unresectable Pancreatic Cancer: A Single-Center… — Europe PMC PMID:41595118
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41595118
- DOI
- 10.3390/cancers18020194
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T00:30:30.908Z
- SHA-256 of the archived text
56ed14bb7fbd879701f0ad17f05a48233d1ede54131cd8ddaff2f74246958887- Stable URL of this page
https://metraipolis.com/documento/dc_1ec51180d24b
How to cite
Prognostic Impact of Unplanned Hospitalization During First-Line Gemcitabine Plus Nab-Paclitaxel Therapy for Unresectable Pancreatic Cancer: A Single-Center… — Europe PMC PMID:41595118 — Europe PMC (en), https://europepmc.org/article/MED/41595118 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1ec51180d24b (Metraipolis archive dc_1ec51180d24b, sha256 56ed14bb7fbd879701f0ad17f05a48233d1ede54131cd8ddaff2f74246958887)
BibTeX
@misc{dc1ec51180d24b,
title = {Prognostic Impact of Unplanned Hospitalization During First-Line Gemcitabine Plus Nab-Paclitaxel Therapy for Unresectable Pancreatic Cancer: A Single-Center… — Europe PMC PMID:41595118},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41595118},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1ec51180d24b; sha256 56ed14bb7fbd879701f0ad17f05a48233d1ede54131cd8ddaff2f74246958887},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41595118. Agents can read the archived copy with the MCP tool read_document.